1. Home
  2. MDXG vs REX Comparison

MDXG vs REX Comparison

Compare MDXG & REX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • REX
  • Stock Information
  • Founded
  • MDXG 2006
  • REX 1980
  • Country
  • MDXG United States
  • REX United States
  • Employees
  • MDXG N/A
  • REX N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • REX Major Chemicals
  • Sector
  • MDXG Health Care
  • REX Industrials
  • Exchange
  • MDXG Nasdaq
  • REX Nasdaq
  • Market Cap
  • MDXG 1.0B
  • REX 1.1B
  • IPO Year
  • MDXG N/A
  • REX N/A
  • Fundamental
  • Price
  • MDXG $7.12
  • REX $32.20
  • Analyst Decision
  • MDXG Buy
  • REX Strong Buy
  • Analyst Count
  • MDXG 1
  • REX 1
  • Target Price
  • MDXG $12.00
  • REX $25.00
  • AVG Volume (30 Days)
  • MDXG 1.2M
  • REX 147.2K
  • Earning Date
  • MDXG 10-29-2025
  • REX 12-02-2025
  • Dividend Yield
  • MDXG N/A
  • REX N/A
  • EPS Growth
  • MDXG N/A
  • REX N/A
  • EPS
  • MDXG 0.27
  • REX 1.49
  • Revenue
  • MDXG $393,442,000.00
  • REX $650,008,000.00
  • Revenue This Year
  • MDXG $19.01
  • REX $3.27
  • Revenue Next Year
  • MDXG $2.36
  • REX $17.11
  • P/E Ratio
  • MDXG $26.29
  • REX $22.27
  • Revenue Growth
  • MDXG 14.77
  • REX N/A
  • 52 Week Low
  • MDXG $5.79
  • REX $16.73
  • 52 Week High
  • MDXG $10.14
  • REX $33.97
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 46.92
  • REX 44.69
  • Support Level
  • MDXG $7.23
  • REX $32.25
  • Resistance Level
  • MDXG $7.63
  • REX $33.97
  • Average True Range (ATR)
  • MDXG 0.41
  • REX 1.03
  • MACD
  • MDXG -0.03
  • REX 0.36
  • Stochastic Oscillator
  • MDXG 29.68
  • REX 42.16

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About REX REX American Resources Corporation

REX American Resources Corp operates as a holding company, which engages in investment in alternative energy and ethanol production entities. Its operating segments include Ethanol and By-Products. Its products include dried distillers grains, modified distillers grains, and non-food grade corn oil.

Share on Social Networks: